Deal-Making
MaxCyte inks electroporation deal with Prime
Deal MakingMaxCyte inks electroporation deal with PrimeMaxCyte inks electroporation deal with Prime
Prime Medicine will have non-exclusive clinical and commercial rights to use MaxCyte’s Flow Electroporation technology and ExPERT platform.